Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The catcher in the gut: Tirzepatide, a dual incretin analog for the treatment of type 2 diabetes mellitus and obesity
Ioannis G. Lempesis, Jun‐Li Liu, Μaria Dalamaga
Metabolism Open (2022) Vol. 16, pp. 100220-100220
Open Access | Times Cited: 20

Showing 20 citing articles:

The Role of Next-Generation Probiotics in Obesity and Obesity-Associated Disorders: Current Knowledge and Future Perspectives
Natalia G. Vallianou, Dimitris Kounatidis, Dimitrios Tsilingiris, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6755-6755
Open Access | Times Cited: 57
Obesity and Peripheral Artery Disease: Current Evidence and Controversies
Ioannis G. Lempesis, Dimitrios Varrias, Μarios Sagris, et al.
Current Obesity Reports (2023) Vol. 12, Iss. 3, pp. 264-279
Open Access | Times Cited: 30
Tirzepatida: Un Avance Revolucionario en el Tratamiento de la Diabetes Mellitus Tipo 2 y la Obesidad
Mariana Chávez
Revista Veritas de Difusão Cientifica. (2023) Vol. 4, Iss. 1, pp. 96-110
Open Access | Times Cited: 25
Physiopathological mechanisms related to inflammation in obesity and type 2 diabetes mellitus
Ioannis G. Lempesis, Vasiliki Georgakopoulou
World Journal of Experimental Medicine (2023) Vol. 13, Iss. 3, pp. 7-16
Open Access | Times Cited: 24
The Kidney in Obesity: Current Evidence, Perspectives and Controversies
Dimitris Kounatidis, Natalia G. Vallianou, Theodora Stratigou, et al.
Current Obesity Reports (2024) Vol. 13, Iss. 4, pp. 680-702
Closed Access | Times Cited: 7
The relation between estimated pulse wave velocity and peripheral arterial disease: A study based on NHANES
M. Ning, Xia Jiang, Songmin Jia, et al.
Vascular (2025)
Closed Access
The Many Facets of PPAR-γ Agonism in Obesity and Associated Comorbidities: Benefits, Risks, Challenges, and Future Directions
Dimitris Kounatidis, Natalia G. Vallianou, Eleni Rebelos, et al.
Current Obesity Reports (2025) Vol. 14, Iss. 1
Closed Access
Obesity and Leukemia: Biological Mechanisms, Perspectives, and Challenges
Dimitrios Tsilingiris, Natalia G. Vallianou, Nikolaos Spyrou, et al.
Current Obesity Reports (2023) Vol. 13, Iss. 1, pp. 1-34
Open Access | Times Cited: 11
Lung cancer and obesity: A contentious relationship (Review)
Vasiliki Georgakopoulou, Ioannis G. Lempesis, Νικόλαος Τράκας, et al.
Oncology Reports (2024) Vol. 52, Iss. 5
Closed Access | Times Cited: 3
Implications of obesity and adiposopathy on respiratory infections; focus on emerging challenges
Ioannis G. Lempesis, Vasiliki Georgakopoulou
World Journal of Clinical Cases (2023) Vol. 11, Iss. 13, pp. 2925-2933
Open Access | Times Cited: 8
Weight Loss Programs: Why Do They Fail? A Multidimensional Approach for Obesity Management
Rabie Khattab
Current Nutrition Reports (2024) Vol. 13, Iss. 3, pp. 478-499
Closed Access | Times Cited: 2
Diet patterns, gut microbiota and metabolic disorders: Perspectives and challenges
Μaria Dalamaga, Christina Tsigalou
Metabolism Open (2024) Vol. 23, pp. 100310-100310
Open Access | Times Cited: 2
The parallel lives of pandemics: COVID‑19 and obesity
Vasiliki Georgakopoulou, Ioannis G. Lempesis, Demetrios�� Spandidos
Experimental and Therapeutic Medicine (2024) Vol. 27, Iss. 5
Open Access | Times Cited: 1
TIRZEPATIDA, AGONISTA DO RECEPTOR DUPLO DE GIP E GLP-1, NO TRATAMENTO DE DIABETES MELLITUS TIPO 2: EFICÁCIA E SEGURANÇA
Rodolfo Alvarenga Bastos, Ana Gabriela Bonfim Lopes, B OLIVIERI, et al.
RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218 (2024) Vol. 5, Iss. 4, pp. e545133-e545133
Open Access | Times Cited: 1
Tizerpatida: a nova promessa contra a obesidade
Giulia Morais Leandro de Carvalho, Laiza Alencar Santos Barros
Brazilian Journal of Health Review (2024) Vol. 7, Iss. 3, pp. e69678-e69678
Open Access | Times Cited: 1
Gut Microbiota–microRNA Interactions and Obesity Pathophysiology: A Systematic Review of Integrated Studies
Hushyar Azari, M. Patricia George, Kembra Albracht‐Schulte
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12836-12836
Open Access | Times Cited: 1
Integrating serum pharmacochemistry and network pharmacology to reveal the mechanism of chickpea in improving insulin resistance
Pei Li, Jiaxian Zhang, Jinyun Wu, et al.
Fitoterapia (2023) Vol. 172, pp. 105750-105750
Closed Access | Times Cited: 3
Eficacia de la tirzepatida en pacientes con diabetes mellitus tipo 2 y obesidad: un innovador fármaco dual
María Gracia Machado Fernández, Etsa Robinson Tsenkush Chamik, Victor Manuel Largo Rivera, et al.
Ciencia Latina Revista Científica Multidisciplinar (2023) Vol. 7, Iss. 1, pp. 2370-2082
Open Access | Times Cited: 2
NEW TREATMENTS FOR OBESITY: DOUBLE AGONIST TWO GIP/ GLP-1 RECEPTORS – TIRZEPATIDE
Gabrielle Molina Pinto, Mariane Csizmar Gonçalves, Pedro Lucas Silveira Duarte, et al.
International Journal of Health Science (2024) Vol. 4, Iss. 12, pp. 2-9
Open Access
O USO DE TIRZEPATIDA NO COMBATE A OBESIDADE: UMA ANÁLISE DOS BENEFÍCIOS E EFEITOS ADVERSOS
Vinicius Camilo Gomes dos Ramos, Juliana Goldfarb de Oliveira
Revista interdisciplinar em saúde (2024) Vol. 11, Iss. Unico, pp. 500-515
Open Access
Page 1

Scroll to top